High-density genotyping and functional SNP localization in the CETP gene

Journal of Lipid Research

Volumn 48, Issue 2, 2007, Pages 434-443

  Thompson, John F ^a   Wood, Linda S ^a   Pickering, Eve H ^a   DeChairo, Bryan ^a   Hyde, Craig L ^a  

^a PFIZER INC   (United States)

Author keywords

Cholesteryl ester transfer protein; Genetics; High density lipoprotein; Single nucleotide polymorphism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BINDING SITE; CHOLESTEROL ESTER TRANSFER PROTEIN GENE; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC GROUP; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHOLESTEROL ESTER TRANSFER PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY;

EID: 33846893443     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600372-JLR200     Document Type: Article

References (36)

1. Brown, M. L., A. Inazu, C. B. Hesler, L. B. Agellon, C. Mann, M. E. Whitlock, Y. L. Marcel, R. W. Milne, J. Koizumi, H. Mabuchi, et al. 1989. Molecular basis of lipid transfer deficiency in a family with increased high-density lipoproteins. Nature. 342: 448-451.
2. Boekholdt, S. M., and J. F. Thompson. 2003. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J. Lipid Res. 44: 1080-1093.
3. Boekholdt, S. M., J-A. Kuivenhoven, G. K. Hovingh, J. W. Jukema, J. J. P. Kastelein, and A. van Tol. 2004. CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr. Opin. Lipidol. 15: 393-398.
4. Boekholdt, S. M., F. M. Sacks, J. W. Jukema, J. Shepherd, D. J. Freeman, A. D. McMahon, F. Cambien, V. Nicaud, G. J. de Grooth, P. J. Talmud, et al. 2005. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment - individual patient meta-analysis of 13,677 subjects. Circulation. 111: 278-287.
5. Lloyd, D. B., M. E. Lira, L. S. Wood, L. K. Durham, T. B. Freeman, G. Preston, X. Qiu, E. Sugarman, P. Bonnette, A. Lanzetti, et al. 2005. Cholesteryl ester transfer protein variants have differential stability but uniform inhibition by torcetrapib. J. Biol. Chem. 280: 14918-14922.
6. Corbex, M., O. Poirier, F. Fumeron, D. Betouille, A. Evans, J. B. Ruidavets, D. Arveiler, G. Luc, L. Tiret, and F. Cambien. 2000. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet. Epidemiol. 19: 64-80.
7. Dachet, C., O. Poirier, F. Cambien, M. J. Chapman, and M. Rouis. 2000. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler. Thromb. Vasc. Biol. 20: 507-515.
8. Le Goff, W., M. Guerin, V. Nicaud, C. Dachet, G. Luc, D. Arveiler, J-B. Ruidavets, A. Evans, F. Kee, C. Morrison, et al. 2002. A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels: interaction with the TaqIB and -629C/A polymorphisms. Atherosclerosis. 161: 269-279.
9. Lu, H., A. Inazu, Y. Moriyama, T. Higashikata, M. Kawashiri, W. Yu, Z. Huang, T. Okamuri, and H. Mabuchi. 2003. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism. J. Mol. Med. 81: 246-255.
10. Thompson, J. F., L. K. Durham, M. E. Lira, C. Shear, and P. M. Milos. 2005. CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis. 181: 45-53.
11. Thompson, J. F., D. B. Lloyd, M. E. Lira, and P. M. Milos. 2004. CETP promoter SNPs in Sp1 binding sites affect transcription and are associated with HDL cholesterol. Clin. Genet. 66: 223-228.
12. Thompson, J. F., M. E. Lira, L. K. Durham, R. W. Clark, M. J. Bamberger, and P. M. Milos. 2003. Polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis. 167: 195-204.
13. Hinds, D. A., L. L. Stuve, G. B. Nilsen, E. Halperin, E. Eskin, D. G. Ballinger, K. A. Frazer, and D. R. Cox. 2005. Whole-genome patterns of common DNA variation in three human populations. Science. 307: 1072-1079.
14. Lira, M. E., D. B. Lloyd, S. Hallowell, P. M. Milos, and J. F. Thompson. 2004. Highly polymorphic repeat region in the CETP promoter induces unusual DNA structure. Biochim. Biophys. Acta. 1684: 38-45.
15. Lloyd, D. B., J. M. Reynolds, M. T. Cronan, S. P. Williams, M. E. Lira, L. S. Wood, D. R. Knight, and J. F. Thompson. 2005. Novel variants in human and monkey CETP. Biochim. Biophys. Acta. 1737: 69-75.
16. Ballantyne, C. M., T. C. Andrews, J. A. Hsia, J. H. Kramer, and C. Shear. 2001. Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels. Am. J. Cardiol. 88: 265-269.
17. Cargill, M., D. Altshuler, J. Ireland, P. Sklar, K. Ardlie, N. Patil, N. Shaw, C. R. Lane, E. P. Lim, N. Kalyanaraman, et al. 1999. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22: 231-238.
18. Morabia, A., E. Cayanis, M. C. Costanza, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and T. C. Gilliam. 2003. Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors. Hum. Mol. Genet. 12: 2733-2743.
19. Chasman, D. I., D. Posada, L. Subrahmanyan, N. R. Cook, V. P. Stanton, and P. M. Ridker. 2004. Pharmacogenetic study of statin therapy and cholesterol reduction. J. Am. Med. Assoc. 291: 2821-2827.
20. Stanssons, P., M. Zabeau, G. Meersseman, G. Remes, Y. Gansemans, N. Storm, R. Hartmer, C. Honisch, C. P. Rodi, S. Bocker, et al. 2004. High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Res. 14: 126-133.
21. Horne, B. D., J. F. Carlquist, L. A. Cannon-Albright, J. B. Muhlestein, J. T. McKinney, M. J. Kolek, J. L. Clarke, J. L. Anderson, and N. J. Camp. 2006. High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene. Ann. Hum. Genet. 70: 524-534.
22. Linsel-Nitschke, P., and A. R. Tall. 2005. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat. Rev. Drug Discov. 4: 193-205.
23. Lamon-Fava, S. 2002. High-density lipoproteins: effects of alcohol, estrogen, and phytoestrogens. Nutr. Rev. 60: 1-7.
24. Kelley, G. A., K. S. Kelley, and Z. V. Tran. 2004. Aerobic exercise and lipids and lipoproteins in women: a meta-analysis of randomized controlled trials. J. Womens Health. 13: 1148-1164.
25. Curb, J. D., R. D. Abbott, B. L. Rodriguez, K. Masaki, R. Chen, D. S. Sharp, and A. R. Tall. 2004. A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J. Lipid Res. 45: 948-953.
26. Sirtori, C. R., L. Calabresi, D. Baldassarre, G. Franceschini, A. B. Cefalu, and M. Averna. 2006. CETP levels rather than polymorphisms as markers of coronary risk: healthy athlete with high HDL-C and coronary disease - effectiveness of probucol. Atherosclerosis. 186: 225-227.
27. Hartung, G. H., J. P. Foreyt, R. E. Mitchell, I. Vlasek, and A. M. Gotto, Jr. 1980. Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men. N. Engl. J. Med. 302: 357-361.
28. Firoozi, S., S. Sharma, and W. J. McKenna. 2003. Risk of competitive sport in young athletes with heart disease. Heart. 89: 710-714.
29. Prestridge, D. S., and G. Stormo. 1993. Signal Scan 3.0. New database and program features. Comput. Appl. Biosci. 9: 113-115.
30. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
31. Liu, A., P. W. Hoffman, W. Lu, and G. Bai. 2004. NF-kB site interacts with Sp factors and up-regulates the NR1 promoter during neuronal differentiation. J. Biol. Chem. 279: 17449-17458.
32. Klerkx, A. H. E. M., M. W. T. Tanck, J. J. P. Kastelein, H. O. F. Molhuizen, J. W. Jukema, A. H. Zwinderman, and J. A. Kuivenhoven. 2003. Haplotype analysis of the CETP gene: not Taq1B, but the closely linked -629C->A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum. Mol. Genet. 12: 111-123.
33. Frisdal, E., A. H. E. M. Klerkx, W. Le Goff, M. W. T. Tanck, J-P. Lagarde, J. W. Jukema, J. J. P. Kastelein, M. J. Chapman, and M. Guerin. 2005. Functional interaction between -629C/A, -971G/A, and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS study. Hum. Mol. Genet. 14: 2607-2618.
34. LeGoff, W., M. Guerin, L. Petit, M. J. Chapman, and J. Thillet. 2003. Regulation of human CETP expression: role of Sp1 and Sp3 transcription factors at promoter sites -690, -629, and -37. J. Lipid Res. 44: 1322-1331.
35. Williams, S., L. Hayes, L. Elsenboss, A. Williams, C. Andre, R. Abramson, J. F. Thompson, and P. M. Milos. 1997. Sequencing of the cholesteryl ester transfer protein 5′ regulatory region using artificial transposons. Gene. 197: 101-107.
36. Hamon, S. C., J. H. Stengard, A. G. Clark, V. Salomea, E. Boerwinkle, and C. F. Sing. 2004. Evidence for non-additive influence of single nucleotide polymorphisms within the apolipoprotein E gene. Ann. Hum. Genet. 68: 521-535.